Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

British piano duo perform at Odeion
2016-10-19

Description: British piano duo  Tags: British piano duo

David Nettle and Richard Markham, better known
as Nettle and Markham, will be performing in the
Odeion on 20 October 2016.
Photo: Supplied

The Odeion School of Music (OSM) at the University of the Free State (UFS) will be hosting one of the world’s foremost piano duos. Nettle and Markham perform in the main concert halls of Europe and with major British orchestras such as the London Philharmonic, the RPO, the CBSO, and the ECO as well as other international orchestras. They also participate in major international festivals such as the Bath, Harrogate, Berlin, Schleswig-Holstein, and BBC Proms.

The British duo have been delighting audiences throughout the musical world for nearly forty years and will perform at the Odeion on the UFS Bloemfontein Campus on 20 October 2016. David Nettle and Richard Markham are considered one of the most entertaining and musically satisfying partnerships performing today.

"We have not heard here until now a piano duo of such exceptional quality. The understanding of the music by both partners is so good that you cannot distinguish by hearing which of them picks up the musical theme. At the same time it is playing full of colour and spontaneous musicality, stirring and ravishing," Vecemi Praha said.

Nettle and Markham's varied recital and concerto repertoire encompasses not only standard works, but also their own distinctive transcriptions. Their highly praised recordings reflect the range of styles they are known to assimilate effortlessly, from Stravinsky’s The Rite of Spring to Sir Malcolm Arnold’s Concertos for two pianos.

In addition to their regular concert schedule, recent seasons have seen them devoting large amounts of time to preparing new recordings - the complete four-hand works of Schumann and Saint-Saëns being the first in a series of projects designed to keep them busy from now until their 40th anniversary seasons in 2017 and 2018.

Event:
Nettle and Markham – two pianos
Date: 20 October 2016
Time: 19:30
Place: Odeion (Bloemfontein Campus)
Cost: R130 (adults), R90 (pensioners), R70 (UFS staff members), R50 (students and learners), R50 (group booking of 10+). Tickets available at Computicket.

For more information contact Ninette Pretorius at +27 51 401 2504.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept